GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Jingxin Pharmaceutical Co Ltd (SZSE:002020) » Definitions » Volatility

Zhejiang Jingxin Pharmaceutical Co (SZSE:002020) Volatility : 21.16% (As of Mar. 04, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Jingxin Pharmaceutical Co Volatility?

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2025-03-04), Zhejiang Jingxin Pharmaceutical Co's Volatility is 21.16%.


Competitive Comparison of Zhejiang Jingxin Pharmaceutical Co's Volatility

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Jingxin Pharmaceutical Co's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Jingxin Pharmaceutical Co's Volatility Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Jingxin Pharmaceutical Co's Volatility distribution charts can be found below:

* The bar in red indicates where Zhejiang Jingxin Pharmaceutical Co's Volatility falls into.



Zhejiang Jingxin Pharmaceutical Co  (SZSE:002020) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhejiang Jingxin Pharmaceutical Co  (SZSE:002020) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


Zhejiang Jingxin Pharmaceutical Co Volatility Related Terms

Thank you for viewing the detailed overview of Zhejiang Jingxin Pharmaceutical Co's Volatility provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Jingxin Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.800 Xinchang East Road, Yulin subdistrict, Zhejiang Province, Xinchang, CHN, 312500
Zhejiang Jingxin Pharmaceutical Co Ltd is an integrated pharmaceuticals enterprise that focuses on manufacturing, R&D, and marketing. It offers finished dosage forms which include tablets, capsules, and injections in the areas of antilipemic, antidiabetic, cholesterolemia, luoroquinolones, cephalosporin, gastrointestinal promotion, anti-inflammatory analgesic, and antibiotics; APIs, and Chinese herbal drugs. The products are sold to overseas markets such as South-east of Asia, South Asia, Latin America and Europe.
Executives
Wang Neng Neng Director
Chen Shao Bi Executives
Wang Guang Qiang Supervisors
Lv Gang Director
Zhou Lin Executives
Yu Yi Ping Supervisors
Chen Mei Li Directors, executives
Zhang Li Wa Directors, executives
Wu Zheng Jie Director

Zhejiang Jingxin Pharmaceutical Co Headlines

No Headlines